BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

621 related articles for article (PubMed ID: 28893938)

  • 1. Epstein-Barr virus-associated lymphomas.
    Shannon-Lowe C; Rickinson AB; Bell AI
    Philos Trans R Soc Lond B Biol Sci; 2017 Oct; 372(1732):. PubMed ID: 28893938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphomatoid granulomatosis and other Epstein-Barr virus associated lymphoproliferative processes.
    Dunleavy K; Roschewski M; Wilson WH
    Curr Hematol Malig Rep; 2012 Sep; 7(3):208-15. PubMed ID: 22814713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epstein-Barr virus-associated lymphoproliferative disorders.
    Grywalska E; Markowicz J; Grabarczyk P; Pasiarski M; Roliński J
    Postepy Hig Med Dosw (Online); 2013 May; 67():481-90. PubMed ID: 23752600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interplay between the Epigenetic Enzyme Lysine (K)-Specific Demethylase 2B and Epstein-Barr Virus Infection.
    Vargas-Ayala RC; Jay A; Manara F; Maroui MA; Hernandez-Vargas H; Diederichs A; Robitaille A; Sirand C; Ceraolo MG; Romero-Medina MC; Cros MP; Cuenin C; Durand G; Le Calvez-Kelm F; Mundo L; Leoncini L; Manet E; Herceg Z; Gruffat H; Accardi R
    J Virol; 2019 Jul; 93(13):. PubMed ID: 30996097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Epstein-Barr virus and the pathogenesis of lymphoma.
    Vockerodt M; Yap LF; Shannon-Lowe C; Curley H; Wei W; Vrzalikova K; Murray PG
    J Pathol; 2015 Jan; 235(2):312-22. PubMed ID: 25294567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Co-infections, inflammation and oncogenesis: future directions for EBV research.
    Rickinson AB
    Semin Cancer Biol; 2014 Jun; 26():99-115. PubMed ID: 24751797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of Epstein-Barr virus association with pediatric non-hodgkin lymphoma in immunocompetent and in immunocompromised patients in Argentina.
    Chabay PA; De Matteo EN; Aversa L; Maglio S; Grinstein S; Preciado MV
    Arch Pathol Lab Med; 2002 Mar; 126(3):331-5. PubMed ID: 11860309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein-Barr virus-associated lymphoproliferative disorders.
    Ambinder RF
    Rev Clin Exp Hematol; 2003 Dec; 7(4):362-74. PubMed ID: 15129648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human immunodeficiency virus (HIV) and Epstein-Barr virus (EBV) related lymphomas, pathology view point.
    Linke-Serinsöz E; Fend F; Quintanilla-Martinez L
    Semin Diagn Pathol; 2017 Jul; 34(4):352-363. PubMed ID: 28506687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epstein-Barr virus detection in non-Hodgkin's lymphoma of the oral cavity: an immunocytochemical and in situ hybridization study.
    Leong IT; Fernandes BJ; Mock D
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Aug; 92(2):184-93. PubMed ID: 11505266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EBV-associated lymphomas in adults.
    Roschewski M; Wilson WH
    Best Pract Res Clin Haematol; 2012 Mar; 25(1):75-89. PubMed ID: 22409825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LMP1-deficient Epstein-Barr virus mutant requires T cells for lymphomagenesis.
    Ma SD; Xu X; Plowshay J; Ranheim EA; Burlingham WJ; Jensen JL; Asimakopoulos F; Tang W; Gulley ML; Cesarman E; Gumperz JE; Kenney SC
    J Clin Invest; 2015 Jan; 125(1):304-15. PubMed ID: 25485679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein-Barr virus (EBV)-associated lymphoid lesions of the head and neck.
    Auerbach A; Aguilera NS
    Semin Diagn Pathol; 2015 Jan; 32(1):12-22. PubMed ID: 25804341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epstein-Barr Virus Type 2 Infects T Cells and Induces B Cell Lymphomagenesis in Humanized Mice.
    Coleman CB; Lang J; Sweet LA; Smith NA; Freed BM; Pan Z; Haverkos B; Pelanda R; Rochford R
    J Virol; 2018 Nov; 92(21):. PubMed ID: 30089703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A20 (TNFAIP3) deletion in Epstein-Barr virus-associated lymphoproliferative disorders/lymphomas.
    Ando M; Sato Y; Takata K; Nomoto J; Nakamura S; Ohshima K; Takeuchi T; Orita Y; Kobayashi Y; Yoshino T
    PLoS One; 2013; 8(2):e56741. PubMed ID: 23418597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malignancies associated with epstein-barr virus: pathobiology, clinical features, and evolving treatments.
    Neparidze N; Lacy J
    Clin Adv Hematol Oncol; 2014 Jun; 12(6):358-71. PubMed ID: 25003566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Knockout of Epstein-Barr virus BPLF1 retards B-cell transformation and lymphoma formation in humanized mice.
    Whitehurst CB; Li G; Montgomery SA; Montgomery ND; Su L; Pagano JS
    mBio; 2015 Oct; 6(5):e01574-15. PubMed ID: 26489865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epstein-Barr virus latent membrane protein-1 oncogene deletions: correlations with malignancy in Epstein-Barr virus--associated lymphoproliferative disorders and malignant lymphomas.
    Kingma DW; Weiss WB; Jaffe ES; Kumar S; Frekko K; Raffeld M
    Blood; 1996 Jul; 88(1):242-51. PubMed ID: 8704180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of B-Cell Oncogenesis Induced by Epstein-Barr Virus.
    Saha A; Robertson ES
    J Virol; 2019 Jul; 93(13):. PubMed ID: 30971472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epstein-Barr Virus (EBV)-Related Lymphoproliferative Disorders in Ataxia Telangiectasia: Does ATM Regulate EBV Life Cycle?
    Tatfi M; Hermine O; Suarez F
    Front Immunol; 2018; 9():3060. PubMed ID: 30662441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.